Opioid receptor modulator dosage formulations | Patent Publication Number 20210030720

US 20210030720 A1
Patent NumberUS 11007179 B2
Application Number17066072
Filled DateOct 8, 2020
Priority DateMar 14, 2013
Publication DateFeb 4, 2021
Original AssigneeAbbvie Inc.
Inventor/ApplicantsTim Costello
Eugeen Maria Jozef Jans
Jens Jozef Ceulemans
Philip Erna H. Heyns
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.